Microbix Biosystems Inc.
MBXBF
$0.19
$0.00-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.12% | 9.46% | -8,345.14% | -97.65% | 89.65% |
| Total Depreciation and Amortization | -4.67% | -1.37% | 7.78% | -3.99% | 62.76% |
| Total Amortization of Deferred Charges | -1.19% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.44% | -5.44% | 10.76% | -9.07% | 12.37% |
| Change in Net Operating Assets | -368.10% | 180.26% | -537.54% | 129.67% | -134.31% |
| Cash from Operations | -3,160.16% | 104.39% | -306.41% | 18.95% | 0.84% |
| Capital Expenditure | -9.11% | 20.40% | 17.67% | -17.78% | 13.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -9.11% | 20.40% | 17.67% | -17.78% | 13.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -29.87% | 95.68% | -1,571.04% | 0.14% |
| Issuance of Common Stock | -- | -- | -- | 3,338.19% | 1,124.62% |
| Repurchase of Common Stock | 16.61% | 21.90% | 64.17% | -45.57% | -62.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -391.29% | 125.86% | -143.08% | 248.60% | -28.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25,248.84% | 100.49% | -269.64% | 1,616.86% | -46.60% |